据彭博社报...查看全文
chuminhua2019-10-20 23:11
10/14,BridgeBio Pharma$BridgeBio Pharma(BBIO)$ 放弃收购其子公司Eidos Therapeutics$Eidos治疗(EIDX)$ 。2017年BridgeBio创办了Eidos以开发AG10,这是用于转甲状腺素蛋白淀粉样变性的药物。第二年,Eidos上市,BridgeBio拥有该公司66%的股份。BridgeBio原计划今年早些时候收购该公司剩余的34%...查看全文
Replix锐璞美股2019-06-27 14:04
$Adaptive生物技术(ADPT)$ /$BridgeBio Pharma(BBIO)$ -明天IPO,ADPT定价$20, BBIO定价 $17, 从定价来看两家公司都比较受市场欢迎。流通股的数量都差不多,123M左右。Viking Global 都是两家的大股东。ADPT走的是当下热点Computational Biology/Machine Learning。BBIO走的是VC模式,持有$Eidos治...查看全文
美股律师郝俊波2019-04-02 10:48
$Eidos治疗(EIDX)$ Eidos Therapeutics Inc(NASDAQ: EIDX)因突发不利消息而令股价下跌,如果您投资该证券受损请点击我们的雪球网EIDX集体诉讼专题页:网页链接查看全文
淘沙见金2018-11-11 01:08
$Eidos Therapeutics(EIDX)$ 非常不错的数据! AG10 Resulted in Average TTR Stabilization Greater than 90% in All Actively Treated Subjects at Day 28. AG10 Significantly Raised Serum TTR Concentrations (p<0.0001) by 50% and 36% in Subjects Administered 800 mg Twice Daily and ...查看全文
greenlandbiotech2018-10-24 03:34
这一次11月的重点关注标的我们特意提前发布,主要是最近市场对小市值药股无论positive还是negative的消息都进行卖空的行为,使得我们需要去适应市场的改变,因此,更建议大家更早的投资那些有着爆点的且值得投资的标的,我们重点推荐关注NASH市场的VKTX(12号) MDGL(12号) GLMD(13号)在11月...查看全文
$Eidos治疗(EIDX)$ 8-K Current report, items 1.01, 2.03, 8.01, and 9.01 Accession Number: 0001193125-19-293984 Act: 34 Size: 263 KB 网页链接
$Eidos治疗(EIDX)$ 8-K - Current report Filed: 2019-10-31 AccNo: 0001564590-19-039164 Size: 449 KBItem 2.02: Results of Operations and Financial ConditionItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory...
$Eidos治疗(EIDX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-10-31 AccNo: 0001564590-19-039169 Size: 9 MB 网页链接
$Eidos治疗(EIDX)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-10-15 AccNo: 0001193125-19-267356 Size: 46 KB 网页链接
$Eidos治疗(EIDX)$ 8-K - Current report Filed: 2019-09-13 AccNo: 0001193125-19-244853 Size: 31 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Eidos治疗(EIDX)$ 8-K - Current report Filed: 2019-09-11 AccNo: 0001193125-19-243001 Size: 48 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibi...
$Eidos治疗(EIDX)$ EFFECT - Notice of Effectiveness Filed: 2019-08-29 AccNo: 9999999995-19-002009 Size: 1 KB 网页链接
$Eidos治疗(EIDX)$ S-3/A [Amend] - Registration statement under Securities Act of 1933 Filed: 2019-08-23 AccNo: 0001193125-19-227896 Size: 650 KB 网页链接
$Eidos治疗(EIDX)$ 8-K - Current report Filed: 2019-08-12 AccNo: 0001193125-19-219038 Size: 34 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Eidos治疗(EIDX)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-08-08 AccNo: 0001193125-19-216833 Size: 77 KB 网页链接